TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types.
TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types.
复制标题
DOI:
10.1016/j.ccr.2012.01.004
复制
发表时间:
2012-02-14
期刊:
影响因子:
50.3
通讯作者:
St Croix B
中科院分区:
文献类型:
--
作者:
Chaudhary A;Hilton MB;Seaman S;Haines DC;Stevenson S;Lemotte PK;Tschantz WR;Zhang XM;Saha S;Fleming T;St Croix B
Current anti-angiogenic agents used to treat cancer only partially inhibit neovascularization and cause normal tissue toxicities, fueling the need to identify therapeutic agents that are more selective for pathological angiogenesis. Tumor Endothelial Marker 8 (TEM8), also known as anthrax toxin receptor 1 (ANTXR1), is a highly conserved cell-surface protein overexpressed on tumor-infiltrating vasculature. Here, we show that genetic disruption of Tem8 results in impaired growth of human tumor xenografts of diverse origin including melanoma, breast, colon, and lung cancer. Furthermore, antibodies developed against the TEM8 extracellular domain blocked anthrax intoxication, inhibited tumor-induced angiogenesis, displayed broad anti-tumor activity and augmented the activity of clinically approved anti-cancer agents without added toxicity. Thus, TEM8 targeting may allow selective inhibition of pathological angiogenesis.
登录
查看更多内容
DOI:
10.1073/pnas.0431098100
发表时间:
2003-04-29
影响因子:
11.1
作者:
Scobie, HM;Rainey, GJA;Young, JAT
通讯作者:
Young, JAT
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
4.8
作者:
Gerber, HP;Condorelli, F;Ferrara, N
通讯作者:
Ferrara, N
影响因子:
11.2
作者:
Cullen M;Seaman S;Chaudhary A;Yang MY;Hilton MB;Logsdon D;Haines DC;Tessarollo L;St Croix B
通讯作者:
St Croix B
影响因子:
64.8
作者:
Bradley, KA;Mogridge, J;Young, JAT
通讯作者:
Young, JAT